Log in
Enquire now
‌

US Patent 10808036 Anti-transferrin receptor antibodies and methods of use

Patent 10808036 was granted and assigned to Genentech on October, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Genentech
Genentech
0
Current Assignee
Genentech
Genentech
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
108080360
Date of Patent
October 20, 2020
0
Patent Application Number
156141490
Date Filed
June 5, 2017
0
Patent Citations
‌
US Patent 10508151 Anti-transferrin receptor antibodies and methods of use
Patent Citations Received
‌
US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides
0
‌
US Patent 11643446 Progranulin variants
0
Patent Primary Examiner
‌
Michael Szperka
0
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10808036 Anti-transferrin receptor antibodies and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us